home / stock / arna / arna quote
$ Last:
Change Percent:
$ Open:
$ Previous Close:
$ High:
$ Low:
0 Volume:
01/01/1970 12:00:00 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Stock Date | Open Price | Close Price | High | Low | Volume |
---|---|---|---|---|---|
2021-03-04 | 73.13 | 71.51 | 74.56 | 70.86 | 1,075,724 |
2021-03-03 | 71.12 | 73.26 | 74.08 | 68.92 | 1,387,708 |
2021-03-02 | 80.53 | 76.81 | 80.53 | 75.89 | 643,144 |
2021-03-01 | 81.57 | 80.08 | 81.84 | 79.96 | 419,727 |
2021-02-26 | 80.43 | 80.35 | 81.37 | 77.52 | 528,992 |
2021-02-25 | 79.42 | 79.49 | 80.8 | 78.06 | 323,228 |
2021-02-24 | 75.97 | 80.1 | 82.25 | 75.97 | 724,857 |
2021-02-23 | 77.22 | 76.56 | 78.985 | 75.24 | 513,351 |
2021-02-22 | 81.14 | 78.65 | 81.57 | 78.46 | 377,357 |
2021-02-19 | 80.73 | 81.11 | 83.89 | 80.19 | 429,800 |
2021-02-18 | 81.52 | 80.47 | 81.52 | 80 | 272,126 |
2021-02-17 | 82.61 | 81.7 | 83.38 | 81.2 | 321,764 |
2021-02-16 | 84.54 | 83.29 | 85 | 81.64 | 538,411 |
2021-02-15 | 82.87 | 83.95 | 84.41 | 81.7 | 523,493 |
2021-02-12 | 82.87 | 83.95 | 84.41 | 81.7 | 523,489 |
2021-02-11 | 82.79 | 83.13 | 83.48 | 81.18 | 480,193 |
2021-02-10 | 81.99 | 81.93 | 83.55 | 80.41 | 471,631 |
2021-02-09 | 81.9 | 81.57 | 83.31 | 81.12 | 431,750 |
2021-02-08 | 80.93 | 81.97 | 82.25 | 80.51 | 393,186 |
2021-02-05 | 80.89 | 81.18 | 81.9 | 79.2 | 504,050 |
Arena Pharmaceuticals Inc. Company Name:
ARNA Stock Symbol:
NASDAQ Market:
Arena Pharmaceuticals Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
- Olorinab investigated in three doses, 10 mg, 25 mg, and 50 mg, for abdominal pain associated with IBS-C & IBS-D - Trial did not meet primary endpoint in broad study population - Moderate to severe pain population at 50 mg showed statistically significant, clinica...
Image source: The Motley Fool. Arena Pharmaceuticals Inc (NASDAQ: ARNA) Q4 2020 Earnings Call Feb 23, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Arena Pharmaceuticals Inc (ARNA) Q4 2020 Earnings Call Transcript...
- Significant pipeline progress with potentially first- or best-in-class drug candidates - Strong cash position of $1.1 billion as of December 31, 2020 Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today provided a corporate update and reported financial results for...